Articoli con mandati relativi all'accesso pubblico - Carl RegilloUlteriori informazioni
Non disponibili pubblicamente: 5
Speculum versus bimanual lid retraction during intravitreal injection
E Rahimy, MS Fineman, CD Regillo, MJ Spirn, J Hsu, RS Kaiser, ...
Ophthalmology 122 (8), 1729-1730, 2015
Mandati: US National Institutes of Health, US Department of Veterans Affairs
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study
MA Greven, S Garg, B Chiu, SP Shah, J Wolfe, HF Fine, DB Roth, ...
British Journal of Ophthalmology 100 (9), 1211-1215, 2016
Mandati: US National Institutes of Health
Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pause
A Sharma, N Parachuri, N Kumar, F Bandello, BD Kuppermann, ...
British Journal of Ophthalmology 105 (2), 149-150, 2021
Mandati: National Institute for Health Research, UK
Macula Society collaborative retrospective study of ocriplasmin for symptomatic vitreomacular adhesion
JI Lim, AR Glassman, LP Aiello, U Chakravarthy, CJ Flaxel, LJ Singerman, ...
Ophthalmology Retina 1 (5), 413-420, 2017
Mandati: US National Institutes of Health
Fluid-based prognostication in n-AMD: type 3 macular neovascularisation needs an analysis in isolation
A Sharma, N Parachuri, N Kumar, F Bandello, BD Kuppermann, ...
British Journal of Ophthalmology 105 (3), 297-298, 2021
Mandati: National Institute for Health Research, UK
Disponibili pubblicamente: 26
Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration
W Chen, D Stambolian, AO Edwards, KE Branham, M Othman, ...
Proceedings of the National Academy of Sciences 107 (16), 7401-7406, 2010
Mandati: US National Institutes of Health
Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial
L da Cruz, JD Dorn, MS Humayun, G Dagnelie, J Handa, PO Barale, ...
Ophthalmology 123 (10), 2248-2254, 2016
Mandati: US National Institutes of Health
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two …
CC Wykoff, F Abreu, AP Adamis, K Basu, DA Eichenbaum, Z Haskova, ...
The Lancet 399 (10326), 741-755, 2022
Mandati: US National Institutes of Health, Juvenile Diabetes Research Foundation
Long-term results from an epiretinal prosthesis to restore sight to the blind
AC Ho, MS Humayun, JD Dorn, L Da Cruz, G Dagnelie, J Handa, ...
Ophthalmology 122 (8), 1547-1554, 2015
Mandati: US National Institutes of Health
Subretinal hyperreflective material in the comparison of age-related macular degeneration treatments trials
AS Willoughby, G Ying, CA Toth, MG Maguire, RE Burns, JE Grunwald, ...
Ophthalmology 122 (9), 1846-1853. e5, 2015
Mandati: US National Institutes of Health
Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16
TD Keenan, E Agrón, A Domalpally, TE Clemons, F van Asten, WT Wong, ...
Ophthalmology 125 (12), 1913-1928, 2018
Mandati: US National Institutes of Health
Pivotal evaluation of an artificial intelligence system for autonomous detection of referrable and vision-threatening diabetic retinopathy
E Ipp, D Liljenquist, B Bode, VN Shah, S Silverstein, CD Regillo, JI Lim, ...
JAMA network open 4 (11), e2134254-e2134254, 2021
Mandati: US National Institutes of Health
Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials
G Ying, BJ Kim, MG Maguire, J Huang, E Daniel, GJ Jaffe, JE Grunwald, ...
JAMA ophthalmology 132 (8), 915-921, 2014
Mandati: US National Institutes of Health
Association between high-risk disease loci and response to anti–vascular endothelial growth factor treatment for wet age-related macular degeneration
A Orlin, D Hadley, W Chang, AC Ho, G Brown, RS Kaiser, CD Regillo, ...
Retina 32 (1), 4-9, 2012
Mandati: US National Institutes of Health
Baseline predictors of 12-month treatment response to ranibizumab in patients with wet age-related macular degeneration
CD Regillo, BG Busbee, AC Ho, B Ding, Z Haskova
American journal of ophthalmology 160 (5), 1014-1023. e2, 2015
Mandati: US National Institutes of Health
Artificial intelligence detection of diabetic retinopathy: subgroup comparison of the EyeArt system with ophthalmologists’ dilated examinations
JI Lim, CD Regillo, SVR Sadda, E Ipp, M Bhaskaranand, C Ramachandra, ...
Ophthalmology science 3 (1), 100228, 2023
Mandati: US National Institutes of Health
Outcomes of eyes with lesions composed of> 50% blood in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)
MM Altaweel, E Daniel, DF Martin, RA Mittra, JE Grunwald, MM Lai, ...
Ophthalmology 122 (2), 391-398. e5, 2015
Mandati: US National Institutes of Health
Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26
D Hadley, A Orlin, G Brown, AJ Brucker, AC Ho, CD Regillo, LA Donoso, ...
Investigative ophthalmology & visual science 51 (4), 2191-2196, 2010
Mandati: US National Institutes of Health
Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: age-related eye disease study 2 report no. 17
JY Jeannette, E Agrón, TE Clemons, A Domalpally, F van Asten, ...
Ophthalmology 126 (2), 261-273, 2019
Mandati: US National Institutes of Health
Understanding retinal vasculitis associated with brolucizumab: complex pathophysiology or Occam’s razor?
A Sharma, N Kumar, N Parachuri, S Singh, F Bandello, CD Regillo, ...
Ocular immunology and inflammation 30 (6), 1508-1510, 2022
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software